Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-05-29

Clinical Trial Update: Asprosın And Tumor Necrosıs Factor-α Levels In Type 2 Dıabetıc Chronıc Periodontitis

View source ↗

Summary

A completed clinical trial evaluating aspirin's effect on tumor necrosis factor-α levels in people with type 2 diabetes and chronic periodontitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)

Snippet

Sponsor: Eda Cetin Ozdemir | Conditions: Periodontal Diseases | Status: COMPLETED